COVID-19 in Combination with HLH in a Child with Severe Aplastic Anemia

Authors

  • Alireza Jenabzadeh
  • Mohammad Naghibi
  • Farzan Safi Dahaj

DOI:

https://doi.org/10.52981/sjms.v17i1.2604

Keywords:

COVID-19, pediatrics, pancytopenia, aplastic anemia

Abstract

Since December 2019, the coronavirus (COVID-19) has spread all over the world. This
disease may present differently in immune-compromised persons. Some of the virus’s
impacts have yet to be identified. In this case report, we report a three-year-and-threemonth-old child with aplastic anemia who was concurrently infected with COVID-19
and HLH (hemophagocytic lymphohistiocytosis). She was referred to our center for
further investigation of aplastic anemia with concurrent fever. Through examination
due to splenomegaly, more evaluations were done. During admission, the PCR test for
COVID-19 became positive, however, because of the fulfillment of the HLH criteria, she
was diagnosed with this disease development. She was treated for HLH with IVIG and
Dexamethasone while getting COVID-19 treatment. Following medicines and followup, her WBC and Hb count started to rise, aside from the PLT count. She continues
to receive PLTs because of her thrombocytopenia till a suitable donor for BMT (Bone
Marrow Transplant) is found. This case scenario highlights the COVID-19 concurrent
complications for paying attention to underlying disease for better diagnosis and
management.

References

[1] Adel, M. and Magdy, A. (2021). SARS-CoV-2 infection in an infant with non-respiratory
manifestations: A case report. Egyptian Pediatric Association Gazette, vol. 69, no. 1,
p. 3.
[2] Deville, J. G., Song, E., and Ouellette, C. P. (2021). COVID-19: Clinical manifestations
and diagnosis in children. UpToDate.
[3] Akçabelen, Y., Yozgat, A. K., Ozkaya-Parlakay, A., et al. (2020). COVID-19 in a child
with severe aplastic anemia. Authorea Preprints.
[4] Mostafavi, S. N., Sadeghizadeh, A., Babaei, S., et al. (2020). Successful recovery
of a child with COVID-19-induced secondary hemophagocytic lymphohistiocytosis.
Archives of Pediatric Infectious Diseases, vol. 10, no. 1, p. e111434.
[5] Arceci, R. J. (2016). Histiocytosis syndromes. Lanzkowsky’s manual of pediatric
hematology and oncology (pp. 407–428). Elsevier.
[6] Brodin, P. (2020). Why is COVID-19 so mild in children? Acta Paediatrica, vol. 109,
no. 6, pp. 1082–1083.
[7] Cyranoski, D. (2020). Why children avoid the worst coronavirus complications might
lie in their arteries. Nature, vol. 582, no. 7812, pp. 324–325.
[8] Zimmermann, P. and Curtis, N. (2021). Why is COVID-19 less severe in children?
A review of the proposed mechanisms underlying the age-related difference in
severity of SARS-CoV-2 infections. Archives of Disease in Childhood, vol. 106, no. 5,
pp. 429–439.
[9] Bunyavanich, S., Do, A., and Vicencio, A. (2020). Nasal gene expression of
angiotensin-converting enzyme 2 in children and adults. JAMA, vol. 323, no. 23,
pp. 2427–2429.
[10] Hyde, Z. (2021). Difference in SARS-CoV-2 attack rate between children and adults
may reflect bias. Clinical Infectious Diseases, vol. 74, no. 1, pp. 152–155.
[11] Boulad, F., Kamboj, M., Bouvier, N., et al. (2020). COVID-19 in children with cancer
in New York City. JAMA Oncology, vol. 6, no. 9, pp. 1459–1460.
[12] Marlais, M., Wlodkowski, T., Vivarelli, M., et al. (2020). The severity of COVID-19 in
children on immunosuppressive medication. The Lancet Child & Adolescent Health,
vol. 4, no. 7, pp. e17–e18.
[13] Turner, D., Huang, Y., Martín-de-Carpi, J., et al. (2020). Corona virus disease 2019 and
paediatric inflammatory bowel diseases: Global experience and provisional guidance
(March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric
Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology
and Nutrition, vol. 70, no. 6, pp. 727–733.
[14] Filocamo, G., Minoia, F., Carbogno, S., et al. (2021). Absence of severe complications
from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic
drugs. Journal of Rheumatology, vol. 48, no. 8, pp. 1343–1344.

Downloads

Published

2022-03-31

Issue

Section

Original Articles